AVALON GLOBOCARE CORP
Avalon GloboCare Corp is a clinical-stage biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology and their clinical applications, as well as healthcare facility management through its core platforms, namely "Avalon Cell" and "Avalon Rehab."
AVALON GLOBOCARE CORP
Industry:
Biopharma Biotechnology Health Care
Founded:
2014-01-01
Address:
Freehold, New Jersey, United States
Country:
United States
Website Url:
http://www.avalon-globocare.com
Total Employee:
1+
Status:
Active
Contact:
732-780-4400
Email Addresses:
[email protected]
Total Funding:
25.15 M USD
Technology used in webpage:
Domain Not Resolving Amazon S3 Laravel Avactis
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-11-08 | Laboratory Services | Laboratory Services acquired by Avalon GloboCare Corp | 31 M USD |
| 2017-10-30 | GenExosome Technologies | GenExosome Technologies acquired by Avalon GloboCare Corp | N/A |
Official Site Inspections
http://www.avalon-globocare.com Semrush global rank: 3.52 M Semrush visits lastest month: 3.7 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Avalon GloboCare Corp"
About :: Avalon GloboCare Corp. (ALBT)
Corporate Overview History: Founded in 2016; successfully uplisted to Nasdaq in December 2018; Headquarters in Freehold, New Jersey; approx. 60 FTEs (including subsidiaries)See details»
Company Information :: Avalon GloboCare Corp. (ALBT)
Company Contact Avalon GloboCare Corp. 4400 Route 9 South Suite 3100 Freehold, NJ 07728 United States [email protected]See details»
Avalon GloboCare Corp - Crunchbase Company Profile & Funding
Avalon GloboCare Corp is a clinical-stage biotech developer and healthcare service provider dedicated to promote and empower high impact, transformative biotechnology and their …See details»
Avalon GloboCare Corp. (ALBT) - Yahoo Finance
Find the latest Avalon GloboCare Corp. (ALBT) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Avalon GloboCare Corp. (ALBT) - Stock Analysis
Nov 22, 2024 About ALBT. Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. The company focuses to …See details»
Avalon GloboCare Signs Definitive Agreement for - GlobeNewswire
Nov 8, 2022 Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, …See details»
Avalon GloboCare—expanding horizons in cancer …
Avalon GloboCare is a global leader in the development of transformative immune effector cell therapies. With 15 autologous and off-the-shelf cell therapy programs for a wide array of hematologic ...See details»
Avalon GloboCare Continues its U.S. Centric Strategy with a New ...
The upcoming 2022 Annual Meeting of Stockholders will be held on December 29, 2022, at 11:00 a.m. Eastern Time. Avalon’s stockholders at the close of business on the record date of …See details»
Investors :: Avalon GloboCare Corp. (ALBT)
Jan 17, 2024 Avalon GloboCare Corp. 4400 Route 9 South Suite 3100 Freehold, NJ 07728 United States [email protected]. Investor Relations. Crescendo Communications, LLC T: (212) 671-1020 [email protected]. …See details»
Avalon GloboCare Announces Closing of Strategic Investment in ...
Avalon GloboCare Announces Closing of Strategic Investment in Laboratory Services MSO, a Leading Clinical Diagnostics and Reference Laboratory Company Avalon GloboCare Corp. …See details»
Board of Directors :: Avalon GloboCare Corp. (ALBT)
He currently serves on the Board of Advisors for Virginia BIO, the statewide biotechnology organization after serving for a decade on the Board of Directors. Mr. Stilley is qualified to …See details»
ALBT Stock Price Quote | Morningstar
Avalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance Plan GlobeNewswire Oct 24, 2024 1:00pm Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 …See details»
Avalon GloboCare Announces the Deployment of Breakthrough
Jan 3, 2023 Avalon GloboCare Corp. (NASDAQ: ALBT) is a clinical-stage biotechnology company dedicated to developing and delivering innovative, transformative cellular …See details»
Avalon GloboCare Provides Year-End Business Update of
Jan 4, 2022 Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, …See details»
Avalon GloboCare Provides Year-End Business Update of Selective ...
Jan 4, 2022 Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, …See details»
Avalon GloboCare Signs Definitive Agreement for …
Nov 8, 2022 Avalon GloboCare Corp. Company to acquire a majority interest in Laboratory Services MSO, LLC, a leading reference laboratory with 2021 unaudited revenue in excess of …See details»
Avalon GloboCare Expands its Cellular Immuno-Oncology
Feb 14, 2022 Avalon GloboCare Corp. (NASDAQ: AVCO) is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering …See details»
Avalon GloboCare Announces Closing of Strategic Investment in ...
Feb 13, 2023 Avalon GloboCare Corp. (NASDAQ: ALBT) is a clinical-stage biotechnology company dedicated to developing and delivering innovative, transformative cellular …See details»